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Sunlnlary 
The csk gene encodes a nonreceptor protein tyrosine kinase that acts in part by regulating the 
activity of src-family protein tyrosine kinases. Since the src-family kinases p56 ~k and p59frn play 
pivotal roles during lymphocyte development, it seemed plausible that p50  "k might contribute 
to these regulatory circuits. Using a gene targeting approach, mouse embryonic stem cell lines 
lacking functional csk genes were generated. These csk "un embryonic stem cells proved capable 
of contributing  to  many  adult  tissues,  notably  heart  and  brain.  However,  although  csk nun 
progenitors colonized the developing thymus, T  and B cell differentiation were both blocked 
at very early stages. This represented a relatively selective interdiction of lymphocyte maturation, 
since csk "uu hematopoietic progenitors supported the development of normal-appearing MAC-1 + 
blood leukocytes, and the successful maturation of granulocyte/macrophage-colony-forming units 
from fetal liver progenitors. We condude that p50  'sk regulates normal lymphocyte differentiation, 
but that it almost certainly does so by acting on targets  other than p561'~ and p59fr n. 
S 
rc-family  protein-tyrosine  kinases  (PTK)'  play  crucial 
roles in regulating the proliferation and differentiation 
of multiple cell types. In part, this reflects their participation 
in the conveyance of signals initiated by the engagement of 
cell surface receptors with external ligands. The src-family 
of nonreceptor PTK genes consists of 10 known members, 
c-src, c-yes, c-fgr, fyn, lyn, Ick, hck, blk, yrk, and rak (reviewed 
in references 1-3). Many of the family members are expressed 
in  specific  hematopoietic  cell  lineages  and  participate  in 
regulating the development of these cells (reviewed in refer- 
ence 4). For example, p56 l'k, expressed early during thymo- 
cyte maturation, delivers signals that permit the maturation 
of CD4 + 8 + cells  from CD4- 8-  progenitors (5),  whereas 
p59fr" regulates activation responses in more mature T-lin- 
eage cells (6, 7). In all src-family kinases studied to date, regu- 
lation of catalytic activity is achieved in part through phos- 
phorylation of a conserved COOH terminal tyrosine, which 
typically results in a 10- to 20-fold decrease in catalysis (8, 9). 
Some evidence suggests that phosphorylation at the COOH- 
1 Abbreviations used in  this paper: ES,  embryonic stem; PTK, protein 
tyrosine kinase; RAG-2, recombination-activating  gene 2. 
terminal tyrosine promotes an intramolecular or intermolecular 
interaction with the SH2 domain of the enzyme, thereby ex- 
cluding other substrates from the active site (10). 
Perhaps not surprisingly, phosphorylation of the COOH- 
terminal regulatory tyrosine of the src-family kinases appears 
to require the activity of an additional set of enzymes, of 
which the best studied is p50  cs~. Structurally related to the 
src-family  PTKs,  but itself lacking the regulatory tyrosine 
phosphorylation site, p50  "~ catalyzes phosphate transfer spe- 
cifically  to the COOH-terminal  tyrosines of p59fY", p53/ 
5Cr" (11), p60  c-src (12),  and p56 ~k (13)  in vitro, and almost 
certainly subserves a similar function in vivo. For example, 
augmented expression of p51Y  ~ suppresses transformation in 
c-src/v-crk transfected fibroblasts (14). Moreover, in csk-defident 
fetal mice (generated by targeted gene disruption in embryonic 
stem cells) the activities of p60  ..... and p59fy  ~ are substantially 
increased. These mice fail to develop beyond embryonic day 
9.5-10.5, and manifest severe defects in neurulation (15, 16). 
Whereas these observations do not exclude the possibility 
that p50  "k may act on other, unrelated targets (e.g., CD45; 
(17), they nevertheless implicate this kinase as a pivotal regu- 
lator of signal transduction via src-family  kinases. 
Immunoreactive p50  csk can be detected at low levels in al- 
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expressed in adult thymus and spleen. This restricted expres- 
sion pattern suggests that pS0  "k may participate in the con- 
trol of lymphocyte activation and/or development (12). Indeed, 
introduction ofcsk expression constructs into a T cell hybrid- 
oma both inhibited TCK signaling and abrogated the ability 
of p56 ~  and p59fr~ to enhance the signaling process  (18). 
Previous studies dearly document the importance of p56 t~k 
and p59frn catalytic function in the development of normal 
T cells. If p50  "k ordinarily regulates the activity of these ki- 
nases, inhibition of p50  "k function should yield animals with 
predictable phenotypes: the thymocytes  from these mice should 
behave as if p56 ~k and p59fr~ were inappropriately activated. 
Unfortunately, the early demise of csk  ~ll fetuses  prevented 
direct investigation of this hypothesis. 
To  evaluate further the in vivo role of p50  "k, we have 
generated chimeric mice by injection of normal and RAG 
(recombination activating gene)-2  ~1~ blastocysts  with em- 
bryonic stem (ES) cells bearing a homozygous disruption of 
csk. In this system, the developmental potential of the csk ~H 
cells was directly assessed using both semi-quantitative anal- 
ysis of chimerism at the level of genomic DNA, and flow 
cytometric analysis of ES cell-derived populations. Remark- 
ably,  despite  the profound block  in development seen  in 
csk  ~1 embryos, ES cells bearing a homozygous disruption 
of the csk gene contributed significantly to numerous ma- 
ture tissues,  including the brain and the heart. These cells 
could not, however, support tymphopoiesis beyond the very 
earliest  stages in either the T  or B cell lineage.  In a formal 
sense, these results demonstrate that disruption of the csk gene 
yields a cell-autonomous defect. Interestingly, csk  n"ll ES cells 
proved perfectly capable of supporting myeloid cell develop- 
ment.  These observations demonstrate that p50  '~  acts  to 
regulate differentiative events beginning at the time of lym- 
phoid specification. 
Materials  and Methods 
Generation ofcsk  "al ES Ceils.  Growth of ES ceils and targeted 
disruption of the first csk allele were performed as described in (6) 
using the gene disruption vector shown in Fig. 1 and described 
earlier (15). PCR was performed on genomic DNA made from 
88 out of  301 G418-resistant clones. PCK products were produced 
using one primer from within the neomycin phosphotransferase 
gene (5'-TATCGCCTTCTTGACGAGTTCTTCTGAGGG)  and a 
second primer from within the targeted gene outside the disrup- 
tion vector (5'-GCCCCTCAGTGGGCACCCCAAGCCCTATA). 
An additional 5' primer (5'-TCCCACCCGCAGGGGAGTTTG- 
GTGGACTAT) was added to the reaction to amplify the endoge- 
nous csk gene. 11 recombinant clones were identified by the pres- 
ence of a visible ethidium-stained band after PCK that was 200 bp 
smaller than that derived from the endogenous csk locus. The dis- 
ruption event was confirmed by genomic blot analysis  as described 
below. Gene disruption of the second allele was performed on four 
individual heterozygote ES clones by exposure to 4 mg/ml G418 
for 8-11 d and expansion  of  surviving  clones  in 250 #g/ml G418 (19). 
Generation of Chimeric Mice.  ES cells were injected  into C57BL/6 
blastocysts which were then transferred into SW foster mothers 
as described (6). Adult and fetal progeny were analyzed to assess 
chimerism by a number of criteria including coat color, Ly9 cell 
surface expression, and detection of the disruption construct by 
semi-quantitative PCR. A RAG  "11 mouse colony was established 
from breeders generously provided by Dr. Frederick W. Air (Har- 
vard Medical  School, Boston, MA) (20). Blastocysts  from these mice 
were injected using the same procedure as that employed from 
C57BL/6 blastocysts. 
lmmunoblot Blot Analysis.  Whole cell  lysates  were prepared from 
ES cells (grown without feeder  cells for three passages) as described 
(21). Samples containing 20/~g of protein were resolved  by SDS- 
PAGE. Proteins were electrophoretically transferred to nitrocellu- 
lose membranes and visualized  according to previous  protocols (15) 
with polyclonal  antiserum specific  for pS0  "k (12). lmmunoreactive 
proteins were detected using a donkey anti-rabbit  peroxidase- 
conjugated second antibody, and visualized  with an enhanced che- 
miluminescence  (ECL) detection system  (Amersham  Corp., Arling- 
ton Heights, IL) followed in some cases by densitometry (model 
UA5; Isco Lincoln, NE). 
Immunopre@itation and Kinase Assays.  Immunoprecipitation  of 
p60  ~-'' proteins isolated from 20 #g of whole cell lysates was per- 
formed using mAb 327 as described (11). One fourth of the reac- 
tion was resolved on 10% SDS-PAGE and visualized using mAb 
327 as described above. The remaining material was resuspended 
in kinase reaction buffer (20 mM Tris-C1, pH 7.5, 10 mM MnCI:, 
1 mM Na2VO4, 0.1% Triton X-100,  1 mM PMSF, 10 /xg/ml 
aprotinin and leupeptin), and 2/xl per reaction of 3,-[32p]ATP 
[3,000 Ci/mmol] containing 2.5/zg of acid-treated enolase were 
added. Kinase reactions were performed for 1, 4, and 10 rain at 
room temperature, stopped by addition of SDS-PAGE sample  buffer 
and boiling for 5 rain, and the products resolved on 10% SDS- 
PAGE. The incorporation of 32p into protein bands was deter- 
mined on an image analyzing system (model BAS2000; Molecular 
Dynamics, Sunnyvale,  CA). Specific  activity was calculated as in- 
corporation of 32p into either enolase or p60  ~-'' per unit of p60  ..... 
protein present. 
Semi-quantitative  PCR.  Genomic  DNA  was  prepared by 
homogenization of tissue culture cells or whole organs in 100 mM 
Tris-Cl, pH 7.5, 100 mM NaC1, 10 mM EDTA, 0.5% sarkosyl, 
and 100/~g/ml proteinase K at 55~  for 2 h or 37~  overnight. 
Extraction  of the  homogenates was  performed with  phenol, 
phenol/chloroform, and chloroform for at least 4 h each and DNA 
was precipitated with 2 vol of ethanol. PCK was performed on 
serial dilutions of DNA from csk  "~ ES cells (using the primers pre- 
viously described to detect the disruption event) to ensure linearity 
of the reaction  conditions.  A standard  curve was produced  by mixing 
known quantities of DNA from csk  "un cells with DNA from wild- 
type ES cells, to  represent different levels of chimerism. PCR 
amplification of chimeric DNA was performed using the combi- 
nation of  primers that detects the disruption event and the endoge- 
nous csk locus on equal amounts of DNA representing different 
levels ofchimerism. The same procedure was performed on several 
dilutions of test DNA from chimeric animals. The amplification 
products were resolved  on 1% agarose  gels, transferred  to nitrocellu- 
lose, and probed with a 32p-labeled oligonucleotide (5'-TGGAGG- 
CAGAGGTCACAGGTGCAGCTGATG). The incorporation of 
3zp was quantitated using the BAS2000 image analyzing system 
or autoradiography. 
Immunocytometry.  Lymphocyte  suspensions were prepared from 
whole organs and red blood cells lysed using ammonium chloride 
as previously  described (7). Cells were stained using anti-CD4PE, 
anti-CDSFITC, anti-CD3FITC, anti-Lyg.1  Biotin, anti-Thyl.2FITC 
(PharMingen, San Diego, CA), and anti-B220PE (Caltag Labs, 
San Francisco, CA). Detection of biotinylated reagents was facili- 
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collected in list mode files on a FACScan  |  flow cytometer (Bec- 
ton Dickinson  Immunocytometry  Systems, San Jose, CA)  and 
analyzed using Reproman Software version 2.07 (Truefacts Soft- 
ware, Seattle, WA). 
CFU-GM Assay and Analysis.  Single  cell suspensions of liver 
from fetal day 17 csk  n~N chimeric mice were prepared by digestion 
in PBS plus 20%  FCS containing 0.75%  collagenase D (Sigma 
Chemical Co., St. Louis, MO) at 37~  for 1 h followed  by passage 
through a 22-gauge needle. The cells were plated at 5  x  103 and 
1  x  104 cells/35 mm dish in 0.3%  agar, over a layer containing 
0.5%  agar and growth factors (50 ng/ml stem cell factor, 2,300 
U/ml IL-3, 20 ng/ml IL-6, 20 ng/ml Ibl, 4 U/ml erythropoietin, 
and 10 ng/ml GM-CSF). The cultures were allowed to develop  for 
8-10 d in 5%  CO2, 5%  02, and 90%  N2. Colonies were har- 
vested and analyzed  using flow cytometry and the csk-specific PCK. 
Giemsa stained slides of cytospin cell preparations were also pre- 
pared. PCK reactions were performed by incubating the cells in 
PCR reaction buffer including 20 pmol oligonucleotide primers, 
10/zg/ml proteinase K, 0.1% Triton X and 0.1% NP-40 at 56~ 
for 1 h followed by 4 min at 94~  0.5/zl of Taq polymerase was 
thereafter added to each reaction, and PCR was performed as de- 
scribed above. 
Results 
Production  of ES  Cells  Lacking  Both  Alleles  of  the  csk 
Gene.  Targeted disruption of the csk gene was performed 
by electroporation of ES cells with the construct shown in 
Fig.  1 A  (15). Homologous recombination deletes most of 
the coding region and replaces it with the neomycin phos- 
photransferase expression cassette and the Escherichia coli lacZ 
gene. Positive/negative selection was achieved by flanking the 
construct with sequences encoding diphtheria toxin (22). After 
electroporation and G418 selection, 301 clones were expanded 
and 11 out of 88 clones tested by PCR were identified as 
having sustained a gene disruption event at the csk locus, These 
results were confirmed by genomic blot analysis (Fig.  1 B). 
All 11 clones contained a single integration of the neomycin 
phosphotransferase  sequence (data not shown). ES cells which 
lacked both alleles of the csk gene were obtained after ex- 
posure ofcsk heterozygotes to 4 mg/ml G418 (19). Genomic 
blot  analysis  of DNA  digested with  HindlII and probed 
with an internal KpnI-EcoRI fragment demonstrated the ap- 
propriate  distribution of wild-type (10  kb)  and disrupted 
(6.8 kb) fragments in cells of the three different genotypes 
(Fig.  1 B). 
To document the effect of homozygous disruption of the 
csk gene, we evaluated putative csk nuu ES cells for the pres- 
ence of immunoreactive p50  "k,  and for  alterations in  the 
specific activity of p60  src. Fig.  2 A  shows that the level of 
p50  "~ protein in ES cells directly reflects  csk  gene dosage; 
csk +/-  cells express 50% less p5(Y  s~ protein compared with 
wild-type cells, while csk  null cells contain no immunoreac- 
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Figure  1.  csk gene  disruption strategy.  (.4) Partial  re- 
striction map of the csk locus  showing  the coding  region 
as a hatched  box. The csk gene disruption  vector  replaces 
the KpnI to NcoI fragment  with a neomycin  resistance 
expression cassette  (pgk-Neo) and/acZ  gene and contains 
the diphtheria toxin gene (pgk-DT) at the 3' end of the 
construct. (B) Southern  blot analysis  of genomic  DNA 
prepared from parental ES cells (+/+), csk heterozygous 
ES cells (+/-), and csk  n~u ES cells (-/-) digested  with 
HindlIl  was probed  with a 1.5-kb KpnI  to EcolLI  ok gene 
fragment. The wild-type  csk allele  resolves at 10 kb and 
the disrupted  allele  migrates  at 6.8 kb on 1% agarose  gels. Figure 2.  Absence  of  p50  "k  and  activation  of 
p60~-5,, in csk  null ES cells. (.4) Immunoblot analysis 
reveals no p50"~ protein in whole cell lysates isolated 
from csk  nuu ES cells (lane 3) as compared with levels 
of p50  "~ detected in csk +/-  ES cells (lane 2)  and 
wild-type ES cells (lane 1), (B) The specific activity 
of p60  c'~ was determined by measuring the kinase ac- 
tivity of p60  c''c immunoprecipitates  isolated  from 
wild-type ES  cells (dark  bars)  and  csk  null ES  cells 
(hatched bars).  Kinase reactions were performed for 1 
and 4 min, measuring the ability of p60  ~'s'C to incor- 
porate  ￿9  y-[32p]ATP by autophosphorylation,  or  by 
phosphorylation of an exogenous enolase  substrate. (C) 
The amount of p61Y  -~ was determined in each sample 
by immunoblot analysis from wild-type cells (lane 1) 
and csk  null cells (lane 2) to calculate the specific activity 
from each reaction. 
466  Involvement of p50  "k in Lymphopoiesis tive p50~'L Moreover, the specific activity of p60  ..... immu- 
noprecipitated from csk "~u ES cells increased at least sixfold 
as compared with the measured activity in wild-type ES cells 
when  judged either by autophosphorylation, or by phosphory- 
lation of an exogenous substrate (Fig. 2 B). There was a similar 
increase in the specific activity of p59fr ~ in csk ~]  ES cells 
(data not shown)￿9 Interestingly, the amount of p60  ~-~' pro- 
tein in csk ~a~ ES cells was markedly less than in wild-type 
cells (Fig.  2 C), an effect previously observed in csk ~11 em- 
bryos (15). Thus by direct evaluation these csk  null ES cells do 
not express a functional csk  gene product. 
csk  ""~ ES Clones Do Not Support Development of Adult Lym- 
phocytes.  To determine if p50  "~ is required for the normal 
development of lymphoid cells, we produced chimeric mice 
using ES cells lacking both alleles of pS0"L Three indepen- 
dently-derived csk  ~  ES cell clones (301A.104,  189A.40,  and 
153A.50), themselves derived from unrelated csk +/-  ES cell 
clones (301A, 189A, and 153A) were injected into C57BL/6 
blastocysts,  which were  then  transferred into  SW  foster 
mothers. The ES cells, derived from the 129/Sv mouse strain, 
yield progeny lymphocytes bearing the Ly9.1 surface marker, 
whereas the C57BL/6 host-derived cells express only the Ly9.2 
allele. 
To document the efficacy of this approach, csk heterozy- 
gote clones 92A, 189A, and 153A were injected into C57BL/6 
blastocysts.  These animals exhibited substantial  coat  color 
chimerism,  and between 10 and 65 % of peripheral blood leu- 
kocytes expressed the Lyg.1 marker (data not shown). Thymo- 
cytes and splenocytes from these mice were analyzed by three- 
color flow cytometry to ensure that normal subpopulations 
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Figure  3.  Three-color flow c/to- 
metric analysis of lymphocytes and 
lymphocyte progenitors from adult 
csk +/-  and csk "ull chimeric  mice. 
(A) Three-color flow cytometry was 
performed on thymocytes and sple- 
nocytes  from  4-wk-old  mice chi- 
meric  for  csk */-  ES  cells  using 
combinations of mAbs shown and 
Ly9.1  biotin/tricolor  streptavidin 
(TriSA). Electronic gating was per- 
formed on Ly9.1 negative cells (left) 
and Ly9.1 positive cells (right) which 
were then analyzed for expression 
of CD4 and CD8  on  thymocytes 
(top) and for expression of B220 and 
CD3  on  splenocytes (bottom).  (B) 
Three-color  flow  cytometry  was 
performed on thymocytes, spleno- 
cytes, and bone marrow cells isolated 
from 4-wk-old csk null chimeric mice 
using combinations of mAbs shown 
and  Ly9.1  TriSA.  Two-parameter 
histograms  are plotted  in the left 
column and histogram overlays  of 
the same samples stained with Lyg.1 
(dark line) and an isotype-matched 
control antibody (thin line) are in the 
right  column.  A  separate  sample 
was stained to demonstrate the ex- 
pression of Ly9.1  on cells derived 
from a Ly9,1-positive age-matched 
strain  (dotted  line). 
467  Gross  et al. were represented in the csk heterozygote-derived  lymphocytes. 
Both csk +/-  (Ly9.1+) and host  (Ly9.1-) populations con- 
tained comparable thymocyte subsets as defined by expres- 
sion of CD4 and CD8,  and exhibited comparable develop- 
ment of mature T  and B cells as defined by the cell surface 
markers B220 and CD3  (Fig.  3 A).  In contrast, the csk  ~un 
ES cells,  derived directly from the heterozygous clones for 
which assays are shown in Fig. 3 A, proved incapable of con- 
tributing to the adult lymphoid compartment. Three-color 
flow cytometry was performed on cells  obtained from the 
thymuses, spleens,  and bone marrow of 14 adult animals, all 
of which were chimeric as judged by coat color. No Ly9.1 + 
cells were detected in any of these tissues  (Fig. 3 B). Despite 
the absence of mature lymphocytes derived from the csk  n~11 
ES cells, host precursors appeared to differentiate normally, 
indicating that the presence of the csk  n~n stem cells had little 
effect on the development of endogenous wild-type progen- 
itors  (see below).  Moreover,  since the defect in  the csk  n~11 
progenitors could not be corrected even by the presence of 
an overwhelming number of wild-type cells in the chimeras, 
loss of csk expression can be said to yield a cell autonomous 
phenotype. 
Contribution  of csk  "utt ES Cells to Other Mouse Tissues.  To 
assess the ability of csk  nun ES cells  to participate in the de- 
velopment of various organs of the whole animal, we devel- 
oped a semi-quantitative PCR assay capable of detecting the 
disrupted csk aUele  in the presence of excess wild-type genomic 
DNA  (see  Materials  and  Methods).  Evaluation  of tissue 
homogenates from thymus, spleen, heart, brain, kidney, liver, 
and bone marrow from 10 csk ~zl chimeric animals revealed 
that csk  n~ll ES cells can contribute to the overall body plan 
(Fig. 4, A  and B), however the level of chimerism was typi- 
cally quite  low.  Consistent  skewing was  observed in  the 
representation of csknull-derived  genomic DNA,  such that 
heart (8% chimerism) and brain (5% chimerism) invariably 
contained the largest representation of csk  ~ull cells, followed 
by kidney and liver (about  1%  chimerism), and thereafter 
by bone marrow, spleen, and thymus. Since this assay was 
performed using entire organs, we cannot identify precisely 
which cells  in each tissue were derived from the csk  nuu ES 
cells. However the overall low level of ES cell contribution 
found in the adult animals demonstrates that  the develop- 
mental potential of csk  null cells in many lineages is impaired 
relative to that of  csk heterozygote ES clones, which produce 
significantly higher levels of chimerism ranging between 10 
and 65%  in  all  organs tested (data not  shown). 
The ability of the csk  null ES clones to produce viable chi- 
meric animals also provides information about the overall de- 
velopmental potential of ES cells with this mutation. We have 
compared the litter sizes  of chimeric mice made from the 
injection of csk  ~ull ES clones with  those observed after in- 
jection of control cells, including wild-type ES cells, csk +/- 
ES  cell  clones,  and fyn nuu  ES  cell  clones  (which  support 
normal embryogenesis; 6).  The csk  null chimeric blastocysts 
produced an average of 2.7 pups per pregnant female out of 
20 pregnancies tested, whereas the average litter size derived 
from the injection of control cells was 5.4 pups per pregnant 
Figure  4.  Detection  of  csk  nca cell DNA by PCR in tissues of adult chi- 
meric mice. Genomic  DNA was isolated from homogenates  of thymus, 
spleen, heart, brain, kidney,  liver, and bone marrow  from  csk  null chimeric 
mice. (A) Semi-quantitative  PCR yielded  fragments  that were resolved 
on 1% agarose,  transferred  to nitrocellulose,  and probed  with an internal 
3,-[32p]ATP-labeled oligonucleotide.  (B) The incorporation  of 32p was 
quantitated using a BAS2000 image  analyzing  system,  and results were 
plotted for each tissue. 
female examining 17 pregnancies (p <0.0005 by Student's t 
test). This difference in litter size indicates, in accord with 
the early lethality observed in csk-/-  homozygote embryos 
(15,  16), that high levels of chimerism are not tolerated by 
the fetal  mouse. 
csk  "~ll ES Clones Can Develop into  Immature  Thymocytes in 
Fetal Chimeric Mice.  Since csk  null ES cells appeared capable 
of contributing to many cell populations, at least at low levels, 
we asked whether csk  null lymphoid progenitors, though un- 
detectable in adult chimeras, might exist in chimeras exam- 
ined at earlier developmental time points. This proved to be 
the case. Fig. 5 presents the results obtained when three-color 
flow cytometric analysis was performed on thymocytes from 
a typical csk  n~11 chimera examined at day 19 of gestation. In 
this animal, 5.8% of the thymocytes were derived from the 
csk  null ES cell line, as judged by Ly9.1 staining.  Interestingly, 
the Ly9.1 + cells in these mice contained a larger proportion 
of less mature CD4-8-  (double negative) cells (12.2%) and 
CD81~ cells (17.8%)  as compared with what was found in 
wild-type (Ly9.1-) thymocytes (5.6 and 3.4%, respectively). 
Concomitantly, the representation of CD4 +  8 + (double posi- 
tive) cells was dramatically reduced (39.4% compared to 83% 
for host double positive cells),  and these cells appeared ab- 
normal in that they expressed reduced levels of CD4. Indeed, 
a large subset of CD4  dim cells, which may represent an early 
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Figure 5.  csk  ~  ES cells can develop into im- 
mature thymocytes in the fetal chimeric mouse. 
Three-color  flow cytometry  was performed  on fetal 
day 19 thymocytes derived from csk  nun chimeric 
mice. Cells were stained  with combinations  of anti- 
CD4PE and anti-CD8FITC, anti-TCtL-~PE and 
anti-CD3 FITC, together with Ly9.1  biotin/TriSA. 
(A) Overlay of Ly9.1 staining (dark line) and con- 
trol mAb (thin line) on fetal thymocytes. (B) CD4 
and CD8 staining of the same cells electronically 
gated to include Ly9.1-negative  cells (left)  and Lyg.1- 
positive cells (right). (C) CD3 versus anti-TCR-~5 
staining of thymocytes  gated on Lyg.I-negative  and 
Ly9.1-positive  cell populations. (/9) Overlay  of CD3 
staining on Ly9.1-positive  cells (thin line) and Lyg.1- 
negative cells (dark line) from same sample as in C. 
thymocyte immigrant  (23),  was  appreciable in the Ly9.1 + 
population.  Very few mature cells, expressing CD3e,  were 
represented among the Ly9.1 § cells (Fig. 5 D). This inability 
of  csk nun  stem  cells  to  yield  phenotypically  mature  in- 
trathymic progeny was confirmed in fetal day  17 chimeric 
mice (data not  shown). 
Reconstitution of RAG.2 n"tt Blastocysts with csk nutl ES Clones. 
Although  the differentiative capability of csk €  T  cell pro- 
genitors appeared to be severely compromised,  it was pos- 
sible that this phenotype resulted from inefficient competi- 
tion with wild-type T-lineage ceils in the chimeric thymus. 
To examine  more  directly  the  innate  ability  of csk nun  in- 
trathymic precursors to give rise to T cell progeny, we gener- 
ated additional chimeras using RAG-2  null blastocysts as hosts. 
In these animals,  thymopoiesis arrests at the CD4-8-,  IL- 
2Rot + stage (19, 24). Hence this environment should permit 
development of csk null cells unhindered by host cell compe- 
tition. Nevertheless, as in the chimeras generated using wild- 
type  blastocysts,  csk n~ll ES  cells  proved  incapable  of con- 
tributing to the development of adult lymphoid populations 
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Figure  6.  Reconstitution  of 
ILAG-2  ~  blastocysts with csk-/- 
ES cells in the fetal thymus. Two- 
color flow cytometry was performed 
on fetal day 19 thymocytes obtained 
from control mice,  chimeric mice 
made  from  RAG-2  n~lL blastocysts 
reconstituted  with csk -  / -  ES cells, 
and RAG-2  ~al controls. Histograms 
of CD4 vs. CD8 and CD3 vs. anti- 
TCR-(~ are shown. 
(data  not  shown).  Analysis  of cskn"ll/RAG-2 "un  chimeric 
mice at fetal day 19 once again defined the limits ofintrathymic 
differentiative capability for csk n"~ cells. Immature CD81~  and 
CD4+8 +  DP  thymocytes, representing  3.8  and  5.1%  of 
total thymocytes respectively (Fig. 6), were once again present, 
however CD3 § cells did not appear in appreciable  numbers. 
Note in particular the absence of a significant CD31~  popu- 
lation,  that  which  ordinarily  represents  about  half of all 
CD4 +  8 + cells (Fig. 6). Even 3'/(3 T  cells, which share a very 
early progenitor with or/3 T cells (25),  fail to develop from 
csk  null precursors (Fig.  6).  Again, a relatively large number 
(3.9%  of the total) of CD4  l~ cells, not immediately related 
to any normally abundant thymocyte population,  emerges 
in the csk nal chimeric thymuses￿9 We conclude that progen- 
itor ceils lacking the csk gene cannot support a normal pro- 
gram of thymocyte maturation, even when permitted to de- 
velop in the relative absence of competitive influences. 
Mature Myeloid Cells  Develop  From csk  ""It Precursors.  The 
inability of csk  ~11 progenitors to give rise to normal T or B 
lymphocytes (Fig.  3 B)  suggested that csk function might 
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Figure 7.  Development ofgranu- 
locyte-myeloid  lineage cells in CFU- 
GM assays. CFU-GM assays were 
performed on  fetal liver cells ob- 
tained from fetal day 17 csk null chi- 
meric mice. (A) Analysis of a colony 
subsequently  shown  by  PCR  to 
contain only csk .ull cells for expres- 
sion of GR-1 or MAC-1  myeloid 
markers  plotted  as  a  single-para- 
meter histogram.  (Thin  lines)  Back- 
ground staining with a control an- 
tibody. (B) Appearance of cells from 
a csk  "al CFU-GM colony revealed 
by Giemsa staining and subsequent 
photomicroscopy. Mature granulo- 
cyte  nuclei  can  be readily appre- 
ciated. be required in a general way to permit hematopoietic cell 
differentiation.  Nevertheless,  detectable numbers of csk null 
cells, representing either stromal cells or other leukocytes, 
appeared in the spleens of chimeric animals as judged by PCR 
amplification of DNA (Fig. 4). Moreover, as much as 4.6% 
of the GR-1 + Mac-1 + splenocytes were ES cell-derived (data 
not shown). To assess the ability of csk  nuu ES clones to de- 
velop within the myeloid linkage, single cell suspensions de- 
rived from livers of csk  €  chimeric fetal mice were allowed 
to develop in a CFU-GM assay (26). PCR analysis of individual 
colonies permitted direct assessment of cellular provenance. 
In three separate experiments, all colonies were found to be 
clonal, and 25% were of csk ~ll origin. These csk n"n myeloid 
colonies contained mature granulocytic and monocytic cells 
as judged by staining with anti-Mac-1 and anti-GR-1 anti- 
bodies (Fig. 7 A), and by histology (Fig.  7 B). We conclude 
that with respect to leukocyte development, the csk "~u mu- 
tation leads to a relatively selective deficiency in lymphopoiesis. 
Discussion 
Considerable evidence supports the hypothesis that src-family 
PTKs play crucial roles in the development and activation 
of hematopoietic cells (reviewed in reference 4). For example, 
p60  ..... itself must be expressed to permit normal osteoclast 
development (27),  whereas a deficiency of p56 ~  leads to a 
very early block in thymopoiesis (28).  The latter example 
provides an especially important paradigm for understanding 
the way in which signals from nonreceptor protein tyrosine 
kinases act to control development. Direct manipulation of 
the kk gene in mouse embryos has demonstrated that p56 ~k 
serves as a component of a sensing mechanism which informs 
developing  thymocytes when  satisfactory expression of a 
TCR-/3 chain protein has occurred (5,  29).  The details of 
this phenomenon were appreciated in part with the realiza- 
tion that provision of augmented p56 t~ activity suppresses 
rearrangement of V3 gene segments, promotes rearrange- 
ment of Vot gene segments, and simultaneously drives the 
proliferative expansion  and  maturation  of CD4+8 +  cells 
(30). Activation of p56 ~k can be stimulated through dephos- 
phorylation of Tyr505, the site of tyrosine phosphorylation 
by p5(Y  'k. Since TyrS05 is also the principle site of tyrosine 
phosphorylation of p56 ~  in vivo (31, 32), there was reason 
to believe  that  p50  ~'k might  serve  as  a component of the 
regulatory machinery that ordinarily permits activation of 
p56 ~k in response to TCR 3  chain expression. 
The p50  "~ kinase is one of an emerging group of non- 
receptor protein tyrosine kinases with apparent specificity for 
the COOH-terminal regulatory tyrosines of src-family mem- 
bers.  Among the csk-like  kinase genes are murine ctk  (33) 
which is the mouse homologue of human MATK  (34), HYL 
(35),  lsk (36),  and the mouse ntk gene (37).  While little is 
known about these recently discovered PTKs, there is reason 
to believe that each may be involved in regulating src-family 
kinase activity in distinct cell lineages. Thus the HYL  gene 
is expressed primarily in myeloid ceils, whereas the MATK 
kinase is expressed at high levels in megakaryocytes. In con- 
trast, p50  "~, though expressed in fetal brain and at very low 
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levels in most adult tissues,  is expressed at highest levels in 
adult thymocytes and splenocytes (11). Hence this protein 
is an attractive candidate for regulating p56 ~k. In its simplest 
form, the hypothesis that pS0  "k acts to regulate p56/c~ sig- 
naling (perhaps to suppress delivery of the Ick-derived signal 
until TCtL-B chain synthesis is achieved) predicts that tar- 
geted disruption of the csk gene should mimic, in thymo- 
cytes, expression of an activated Ick mutant transgene. We 
have tested this  prediction  directly,  and find instead that 
p50  "k plays  a much more fundamental role in  regulating 
lymphocyte development. 
Several important features of p50  c~k function were illumi- 
nated by examining chimeric mice generated using csk  n"ll ES 
cells. First, ES cells lacking p50  "~ protein are indistinguish- 
able from wild-type cells with respect to in vitro growth prop- 
erties, even though the activity of p60 ..... in such cells  is 
significantly elevated (Fig.  2). Thus, p50  "k does not partici- 
pate in any unique way in the control of routine cell growth. 
This observation was, in effect, expected since csk-/-  em- 
bryos develop at least until day 9.5 of gestation (15, 16). At 
the same time, however, the ability of cste  n~l~ ES cells to con- 
tribute to histiogenesis in the mouse was severely impaired. 
Only a few percent of the ceils in most tissues were derived 
from the csk n':'n ES cells rather than the host blastomeres. 
One intriguing feature of the csk null ES cells was the sys- 
tematic variation in their ability to contribute to adult tissues. 
Thus the level of chimerism in the heart and brain, though 
much lower than that observed using csk § / §  ES cells, was 
nevertheless >20-fold better than that seen in the thymus or 
spleen (Fig. 4). Although we were unable to define precisely 
which cells in the heart and brain were ES cell derived, the 
differential impairment wrought by blocking csk expression 
argues that this PTK functions differentially to control the 
maturation of selected cell lineages. 
This specificity of p50  '~ effects can be seen most clearly 
in hematopoietic populations. Precursors derived from csk  n'~ll 
ES cells cannot support normal lymphopoiesis, but instead 
give rise only to very immature cell populations that never 
express normal antigen receptor complexes and that disap- 
pear shortly after birth. This represents a defect peculiar to 
the lymphoid lineage among white blood cells, since mature- 
appearing granulocytes and monocytes differentiate readily 
from csk ~un  hematopoietic progenitors  and  can  be  found 
among adult splenocytes. It is possible that the HYL gene 
product, or another related kinase, regulates myeloid cell de- 
velopment (much as p50  ok controls lymphopoiesis), permit- 
ting appropriate differentiation even in a csk ~  background. 
Importantly, both T and B cell generation are effectively sty- 
mied in chimeras made using csk nun ES cells, implying either 
that p50 'sk acts in a precursor cell common to both popula- 
tions (the so-called lymphoid stem cell; 25) or that both T 
and B cell precursors independently traverse developmental 
checkpoints that require p50  "k activity. 
Regardless of the site of action of p50  "k in lymphopoi- 
esis,  the  characteristics  of  the  defect  observed  in  csk  '~'ll 
thymocytes permit important conclusions regarding its func- 
tion.  We initiated these studies with the expectation that 
p500~ might participate in regulating p56 kk or p59frn. How- ever inappropriate activation of p56 ~k promotes, rather than 
suppresses,  the development  of CD4+8 + thymocytes,  and 
activated p59f~, even when expressed at high levels in im- 
mature thymocytes, does not perturb T cell development (5, 
21, and data not shown). Our data are most compatible with 
the view that p50  "k acts on targets other than the src-family 
kinases known to regulate T  cell development.  The recent 
observation that  p50  ~sk can phosphorylate  and  activate the 
CD45 phosphotyrosine phosphatase  supports this view, in 
the sense that there exist demonstrable substrates for p50  '~k 
other  than  src-family kinases. 
What can be said of the intrathymic process regulated by 
p50"~?  Clearly,  the activity of this protein is not required 
to permit colonization of the fetal thymic anlage by hemato- 
poietic stem cells, since the level of chimerism in early T-lin- 
eage precursors approaches the maximum  that  can be seen 
in any tissue. However a very substantial proportion of these 
cells,  nearly  10% when wild-type hlastocysts were used as 
hosts and an even larger fraction in RAG  nun blastocyst recon- 
stitutions,  was  phenotypically  CD41~  -  (Figs.  5  and  6). 
Cells  with  this phenotype,  while exceedingly rare  among 
normal thymocytes, reportedly contain very early progenitors 
capable of giving rise to either T  or B lymphocytes (23). It 
is therefore attractive to propose that csk  n~n progenitors suc- 
cessfully  colonize  the  thymus  as  CD4 l~  cells,  but  that 
differentiation  thereafter  proceeds  very  poorly,  since  the 
representation of CD4- 8 -, CD4- 8 l~  and CD4 § 8 § cells is 
far less than what would be expected given the abundance 
of the CD41~  precursors.  It is worth noting that the ab- 
sence of csknuU-derived lymphocytes in the adult mouse thy- 
mus, when significant numbers of immature thymocytes are 
present in fetal thymuses, means that csk nun stem cells, which 
in principle should continue to populate the thymus through- 
out life in small numbers, become progressively less able to 
compete  effectively,  even  when  matched  against  RAG  nuu 
progenitors. This observation emphasizes the pivotal role of 
this nonreceptor  PTK in regulating  thymopoiesis. 
Lastly,  we note that  our observations do not necessarily 
undermine  the assertion  that  p50  cSk controls p56 ~k activity 
and hence the maturation  of CD4 +  8 + cells from CD4- 8- 
thymoblasts.  Instead,  since p50  ~sk clearly regulates an even 
earlier developmental transition,  the involvement of pS0  ~k 
in modulating  p56 ~k activity could not be addressed.  De- 
tailed analysis of the stage-specific functions of pS0  "Sk will re- 
quire novel strategies to direct elimination  of this protein, 
or inhibition of its activity, in selected thymocyte subpopu- 
lations  (38).  For the present,  we conclude that  expression 
of pS0  '~k is selectively required for the satisfactory matura- 
tion of early lymphoid progenitors. Elucidation of the mech- 
anism whereby pSO  '~k entrains lymphopoiesis should also il- 
luminate the role of this kinase, and its structural relatives, 
in controlling  development in other cell lineages. 
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